Patients prescribed SGLT2 inhibitors less likely to exhibit nodule growth and to undergo a surgical intervention.

For patients with diabetes and early-stage pulmonary malignancies, administration of a sodium-glucose cotransporter 2 ...

SGLT2 is "highly expressed in early lung adenocarcinoma and its precursor lesions, including atypical adenomatous hyperplasia ...

The oral targeted therapy sevabertinib led to tumor reduction and manageable side effects in patients with HER2-mutant non-small cell lung cancer (NSCLC), according to data from a trial led by ...

Some 77% of patients saw their tumours shrink, 8% saw them completely disappear, and 69% saw partial shrinkage of their ...

Physicians at Health Hospital are diagnosing lung cancer earlier after the hospital recently implemented 3D technology to support its robotic lung biopsy systems. By using robotic biopsy systems ...

Investing.com -- bioAffinity Technologies Inc (NASDAQ:BIAF) stock surged 14% on Thursday after the biotechnology company announced it received a notification of allowance from the United States Patent ...

Aiming to identify potential cancers in children, researchers at a major Dayton university are utilizing AI to develop a ...

The US Patent and Trademark Office will issue BIAF a new patent on its flow cytometry+AI platform that detects lung cancer as ...

Frederick Health Medical Group is outpacing national averages by detecting nearly 40% of lung cancers at Stage 1 with 3D imaging and robotic bronchoscopy.

A state-of-the-art health screening van launched this month is bringing advanced imaging technology and health education directly to New Yorkers who are at the greatest risk of developing lung cancer.